| 引用本文: | 郑彬彬,叶曼,李晓静.唑来膦酸联合用药治疗老年女性骨质疏松患者的疗效观察[J].中国现代应用药学,2013,30(6):682-684. |
| ZHENG Binbin,YE Man,LI Xiaojing.Observation of the Effect for Elderly Women's Osteoporosis Using Zoledronic Acid Combination[J].Chin J Mod Appl Pharm(中国现代应用药学),2013,30(6):682-684. |
|
| 本文已被：浏览 2571次 下载 1667次 |
码上扫一扫！ |
|
|
| 唑来膦酸联合用药治疗老年女性骨质疏松患者的疗效观察 |
|
郑彬彬1,2,3, 叶曼1,2,3, 李晓静1,2,3
|
|
1.温州医学院附属第二医院麻醉科，浙江 温州 325027;2.温州医学院疼痛医学研究所，浙江 温州 325027;3.中华医学会疼痛学会第八临床中心，浙江 温州 325027
|
|
| 摘要: |
| 目的 探讨唑来膦酸及鲑鱼降钙素联合钙尔奇D、阿法骨化醇、复方骨肽注射液治疗老年女性骨质疏松症的疗效。方法 选取40例老年女性骨质疏松性胸腰椎疼痛患者随机分为两组，对照组服用钙尔奇D片(钙尔奇D600)、阿法骨化醇，鲑鱼降钙素注射液、治疗组在对照组的基础上加用唑来膦酸注射液和复方骨肽注射液，两组均连续治疗半年，观察治疗前后的骨密度和疼痛变化。结果 两组治疗后骨密度均明显上升。与治疗前比较差异有统计学意义(P<0.05)。治疗后治疗组骨密度明显高于对照组，差异有统计学意义(P<0.05)。治疗后两组VAS评分均明显下降，与治疗前比较差异有统计学意义(P<0.05)，治疗后治疗组VAS评分下降程度高于对照组，差异有统计学意义(P<0.05)。结论 唑来膦酸及鲑鱼降钙素注射液联合钙尔奇D、阿法骨化醇、复方骨肽注射液治疗老年女性骨质疏松性胸腰椎压缩性骨折患者安全、临床疗效好，优于钙尔奇D片(钙尔奇D600)、阿法骨化醇，鲑鱼降钙素注射液三者合用的治疗方案。 |
| 关键词: 老年女性骨质疏松 唑来膦酸 联合用药 |
| DOI： |
| 分类号: |
| 基金项目: |
|
| Observation of the Effect for Elderly Women's Osteoporosis Using Zoledronic Acid Combination |
|
ZHENG Binbin1,2,3, YE Man1,2,3, LI Xiaojing1,2,3
|
|
1.Department of Anesthesiology, the Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325027, China;2.Institute of Pain Medical Research of Wenzhou Medical College, Wenzhou 325027, China;3.The Eighth Clinical Center of CASP, Wenzhou 325027, China
|
| Abstract: |
| OBJECTIVE To investigate the effect of zoledronic acid combinated salmon calcitonin see calcimar, Caltrate D, alfacalcidol and bone-peptide injection cure old osteoporosis. METHODS Forty cases of thoracolumbar pain of osteoporosis patients were randomly divided into two groups: The control group received salmon calcitonin see calcimar, Caltrate D, alfacalcidol, the therapeutic group received zoledronic acid and bone-peptide injection besides salmon calcitonin see calcimar, Caltrate D, calcitonin. The two groups received six months therapia. Observe the BMD and pain before and after the therapy. RESULTS The BMD of two groups both rised(P<0.05). The BMD of therapeutic group is higher than the control (P<0.05). The VAS score of two groups both descend(P<0.05). The VAS score of therapeutic group is lower than the control (P<0.05). CONCLUSION Zoledronic acid combinated salmon calcitonin see calcimar, Caltrate D, alfacalcidol and bone-peptide injection is a safe curation for old osteoporosis, and more effective than the curation used salmon calcitonin see calcimar, Caltrate D and alfacalcidol together. |
| Key words: elderly women's osteoporosis zoledronic acid combinated medication |
